Greenwich LifeSciences, Inc. ( GLSI) - Stock Earnings
GLSI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.2 million USD | — USD |
| 2025Q4 | -7.9 million USD | — USD |
| 2026Q1 | -5.7 million USD | 3558 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GLSI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.9 million USD | — USD |
| 2024 | -15.8 million USD | — USD |
| 2025 | -19.4 million USD | — USD |
| 2026 Est. | — | — |
GLSI
Price: $24.40
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30476
Market Capitalization: 326.6 million